Skip to main content
Marshall Glesby, MD, Infectious Disease, New York, NY, New York-Presbyterian Hospital

MarshallJayGlesbyMDPhD

Infectious Disease New York, NY

HIV/AIDS Medicine

Professor of Medicine, Weill Cornell Medical College

Dr. Glesby is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Glesby's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Infectious Disease, 1992 - 1996
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1989 - 1992
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1989

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1997 - 2023
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Top Doctors: New York Metro Area Castle Connolly, 2013-2014
  • Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015
  • Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2015

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Moderate Alcohol Use Is Not Associated with Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus–Coinfected Women: A Prospective Cohort Study  
    Phyllis C Tien, Marshall J Glesby, Michael Augenbraun, Marion G Peters, Clinical Infectious Diseases

Lectures

  • CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV+ /AML Patient: A Case Report from the Impaact P1107 Observational StudyClinically Re... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Other

Press Mentions

  • Use of Dexamethasone, Remdesivir Against COVID-19 Varied Widely Across U.S. Health Systems
    Use of Dexamethasone, Remdesivir Against COVID-19 Varied Widely Across U.S. Health SystemsAugust 18th, 2021
  • Researchers Report Third Case of HIV Remission After Stem Cell Transplant Using Umbilical Cord Blood
    Researchers Report Third Case of HIV Remission After Stem Cell Transplant Using Umbilical Cord BloodFebruary 16th, 2022
  • Mortality Gap Narrows Between Patients with HIV, General Population
    Mortality Gap Narrows Between Patients with HIV, General PopulationJuly 9th, 2021
  • Join now to see all

Grant Support

  • Complications Of Chronic Viral InfectionsNational Institute Of Allergy And Infectious Diseases2008–2011
  • A5229 Lipoatrophy StudyNational Center For Research Resources2007
  • Study Of Safety And Efficacy Of Rhgh A/O Rosiglitazone In HIVNational Center For Research Resources2006–2007
  • Growth Hormone And Rosiglitazone For Visceral AdoposityNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2007
  • Suppressive Long-Term Antiviral Management Of HCV And HIV Coinfected SubjectsNational Center For Research Resources2005–2007
  • Growth Hormone And Rosiglitazone For Hiv-Associated LipodystrophyNational Center For Research Resources2005
  • A5127: PH II Trial/ Adefovir Dipivoxil/ Tenofovir Disoproxil Fumarate/ HEP B/ HNational Center For Research Resources2005
  • A5163: Phase II, Study Of Alendronate In HIV W/ Decreased BMDNational Center For Research Resources2004–2005
  • Growth Hormone And Rosiglitazone For Visceral AdiposityNational Institute Of Diabetes And Digestive And Kidney Diseases2004
  • A5127: PH. II Trial/ Adefovir Dipivoxil/ Tenofovir Disoproxil Fumarate/ HEP B/ HNational Center For Research Resources2004

Hospital Affiliations